This compound is a derivative of raloxifene, modified with a tert-butyldimethylsilyl (TBDMS) protecting group on the 4' phenol and retaining a hydroxy group at the 6-position. It is primarily used as a reference standard or impurity in active pharmaceutical ingredient (API) manufacturing for raloxifene-related products.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 174264-46-1
6-tert-Butyldimethylsilyl-4'-hydroxy Raloxifene
pharmaceutical raw material
Raloxifene hydrochloride
pharmaceutical raw material
Raloxifene 6-glucuronide
pharmaceutical raw material
Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-|A-D-glycopyranuronate)
pharmaceutical raw material
Riluzole
pharmaceutical raw material
Amiloride hydrochloride dihydrate
pharmaceutical raw material
[6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]{4-[2-(piperidin-1-yl)ethoxy]phenyl}methanone
pharmaceutical raw material
4-Hydroxy Raloxifene
pharmaceutical raw material
[2-[4-[tert-butyl(dimethyl)silyl]oxyphenyl]-6-hydroxy-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone
YYSIXGNGLSNJGQ-UHFFFAOYSA-N
CC(C)(C)[Si](C)(C)OC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=CC=C(C=C4)OCCN5CCCCC5
—